Search Results 6001-6010 of 25088 for oral

1. Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

   Eligible primary tumor locations are oropharynx, oral cavity, hypopharynx, and larynx. Participants must not have received prior systemic therapy for R/M ...

2. Throat cancer - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Oropharynx Cancer Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Plastic ...

3. Throat cancer - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Oropharynx Cancer Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Plastic ...

4. Squamous cell carcinoma of the skin - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Radiation Oncology. Doctors who treat this condition. Edit search filters. close. Narrow your search. By location. Phoenix ...

5. Phase 1/2 Study Of MRTX1719 In Solid Tumors With MTAP Deletion - Mayo Clinic

   swallow oral medications. - Cardiac abnormalities. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 11/10/23 ...

6. Probing the molecular drivers of meningioma - Mayo Clinic

   Oral medications might be possible eventually, as meningiomas lie outside the blood-brain barrier. "The issues of drug delivery that affect glioblastoma ...

7. A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism - Mayo Clinic

   Use of bisphosphonates (oral or IV) or denosumab within 2 years prior to Visit 1. 9. Non-hypocalcemic seizure disorder with a history of a seizure within 26 ...

8. MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma - Mayo Clinic

   * Subjects on prior intravenous therapy (e.g., chemotherapy or checkpoint inhibitors), or prior oral therapy (e.g.,proto-oncogene B-RAF or mitogen-activated ...

9. Salivary gland tumors - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...

10. A Study to Investigate Intravenous Tocilizumab in Patients with Moderate-to-Severe COVID-19 Pneumonia (enrolling by invitation only) - Mayo Clinic

    Receipt of oral anti-rejection or immunomodulatory drugs (including TCZ) within the past 3 months;; Participation in other drug clinical trials ...